These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2522475)

  • 21. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchial responsiveness to hyperventilation in children with asthma: inhibition by ipratropium bromide.
    Wilson N; Dixon C; Silverman M
    Thorax; 1984 Aug; 39(8):588-93. PubMed ID: 6236576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy.
    Patrick DM; Dales RE; Stark RM; Laliberte G; Dickinson G
    Chest; 1990 Aug; 98(2):295-7. PubMed ID: 2142915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of inhaled ipratropium bromide on methacholine and exercise provocation in asthmatic children.
    Boner AL; Vallone G; De Stefano G
    Pediatr Pulmonol; 1989; 6(2):81-5. PubMed ID: 2522620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The protective effect of ipratropium bromide aerosol against bronchospasm induced by hyperventilation and the inhalation of allergen, methacholine and histamine.
    Clarke PS; Jarrett RG; Hall GJ
    Ann Allergy; 1982 Mar; 48(3):180-3. PubMed ID: 6461281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.
    Thiessen B; Pedersen OF
    Respiration; 1982; 43(4):304-16. PubMed ID: 6213991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of salbutamol, ipratropium bromide and cromolyn sodium on prostaglandin F2 alpha-induced bronchospasm.
    Georgopoulos D; Giulekas D; Ilonidis G; Sichletidis L
    Chest; 1989 Oct; 96(4):809-14. PubMed ID: 2529105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nebulized ipratropium bromide in the treatment of acute asthma.
    Bryant DH
    Chest; 1985 Jul; 88(1):24-9. PubMed ID: 2861067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of fog-induced bronchospasm by high doses of ipratropium bromide in asthmatics.
    Simone P; Robuschi M; Vaghi A; Fasano W; Bianco S
    Respiration; 1986; 50 Suppl 2():209-11. PubMed ID: 2951808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salbutamol and ipratropium bromide solution in the treatment of bronchospasm in asthmatic children.
    Boner AL; De Stefano G; Niero E; Vallone G; Gaburro D
    Ann Allergy; 1987 Jan; 58(1):54-8. PubMed ID: 2948430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchoconstriction by nebulized metabisulfite solutions (SO2) and its modification by ipratropium bromide.
    Seale JP; Temple DM; Tennant CM
    Ann Allergy; 1988 Sep; 61(3):209-13. PubMed ID: 2970816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholinergic blockade in the prevention of exercise-induced asthma.
    Hartley JP; Davies BH
    Thorax; 1980 Sep; 35(9):680-5. PubMed ID: 6449753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of Duovent on bronchospasm induced by carbachol in comparison with each of its components.
    Carnimeo N; Resta O; Foschino Barbaro MP; Picca V; D'Amore ME; Garofalo G; Carnimeo R
    Respiration; 1986; 50 Suppl 2():152-4. PubMed ID: 2951795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of inhaled salmeterol on sulfur dioxide-induced bronchoconstriction in asthmatic subjects.
    Gong H; Linn WS; Shamoo DA; Anderson KR; Nugent CA; Clark KW; Lin AE
    Chest; 1996 Nov; 110(5):1229-35. PubMed ID: 8915226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Airways responses to ipratropium bromide do not vary with time in asthmatic subjects. Studies of interindividual and intraindividual variation of bronchodilatation and protection against histamine-induced bronchoconstriction.
    Ihre E; Larsson K
    Chest; 1990 Jan; 97(1):46-51. PubMed ID: 2136826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asthma: comparative bronchodilator effects of ipratropium bromide and isoproterenol.
    Yeager H; Weinberg RM; Kaufman LV; Katz S
    J Clin Pharmacol; 1976 Apr; 16(4):198-204. PubMed ID: 131133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of fog-induced bronchospasm by Duovent and its components (fenoterol, ipratropium bromide) in asthmatics.
    Simone P; Robuschi M; Vaghi A; Fasano W; Bianco S
    Respiration; 1986; 50 Suppl 2():192-5. PubMed ID: 2951804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of bronchial response to ipratropium bromide by respiratory impedance measurement in asthmatics.
    Wouters EF; Quaedvlieg M; Mostert R; Polko AH; Visser BF
    Int J Clin Pharmacol Ther Toxicol; 1989 Mar; 27(3):145-9. PubMed ID: 2524449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.